These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2159443)

  • 1. Superinfection by Epstein-Barr virus of a subset of Raji cells is independent of HLA class II-antigens.
    Faggione A; Zompetta C; Cirone M; Barile G; Frati L; Acolla R
    Int J Cancer; 1990 May; 45(5):989. PubMed ID: 2159443
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
    Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
    J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus receptor is distinct from the C3 receptor.
    Wells A; Koide N; Stein H; Gerdes J; Klein G
    J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA type of EBV-transformed human B cell lines.
    Hurley CK; Johnson AH
    Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1G. PubMed ID: 18432643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation-associated Epstein-Barr virus antigens as targets for immune attack.
    Masucci MG; Gavioli R; de Campos-Lima PO; Zhang QJ; Trivedi P; Dolcetti R
    Ann N Y Acad Sci; 1993 Aug; 690():86-100. PubMed ID: 7690218
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
    Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
    Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Epstein--Barr virus early protein induces cell fusion.
    Bayliss GJ; Wolf H
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7162-5. PubMed ID: 6273915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some Epstein-Barr virus-transformed B lymphoblastoid cell lines have an altered structure around the mixed lymphocyte culture-inducing domain on DR molecules.
    Nagayoshi T; Morito F; Kaneoka H; Yamaguchi M
    Fukuoka Igaku Zasshi; 1986 May; 77(5):287-92. PubMed ID: 3017826
    [No Abstract]   [Full Text] [Related]  

  • 10. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
    Rowe M; Rooney CM; Edwards CF; Lenoir GM; Rickinson AB
    Int J Cancer; 1986 Mar; 37(3):367-73. PubMed ID: 3005176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus carried by Raji cells: a mutant in early functions?
    Kallin B; Klein G
    Intervirology; 1983; 19(1):47-51. PubMed ID: 6298144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization of the Epstein-Barr virus/C3d receptor (CR2) in the human Burkitt B lymphoma cell, Raji.
    Gauffre A; Viron A; Barel M; Hermann J; Puvion E; Frade R
    Mol Immunol; 1992 Sep; 29(9):1113-20. PubMed ID: 1323059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Events related to Epstein-Barr virus binding and superinfection of Raji cells.
    Barile G; Di Certo MG; Cirone M; Frati L; Pontieri GM; Faggioni A; Di Renzo L
    Intervirology; 1994; 37(5):245-51. PubMed ID: 7698879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P; Ehlin-Henriksson B; Klein G
    J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM
    Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.